Q1 2014 Holdings
Filed 2014-05-08 | 24 holdings | $33.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc.(ALNY) | COM | 02043Q107 | $31.6M | 471,288 | 94.3% |
| Celgene Corp(CELG) | COM | 151020104 | $305.0K | 2,184,649 | 0.9% |
| Isis Pharmaceuticals Inc. | COM | 464330109 | $272.3K | 6,301,526 | 0.8% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $249.0K | 3,513,496 | 0.7% |
| Incyte Corp(INCY) | COM | 45337C102 | $221.2K | 4,133,790 | 0.7% |
| Alexion Pharmaceuticals Inc.(ALXN) | COM | 015351109 | $110.7K | 727,428 | 0.3% |
| Vertex Pharmaceuticals Inc.(VRTX) | COM | 92532F100 | $99.3K | 1,404,445 | 0.3% |
| Medivation Inc. | COM | 58501N101 | $94.0K | 1,459,706 | 0.3% |
| Synageva BioPharma Corp. | COM | 87159A103 | $78.0K | 939,957 | 0.2% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $71.7K | 5,641,564 | 0.2% |
| Regeneron Pharmaceuticals Inc.(REGN) | COM | 75886F107 | $67.0K | 223,000 | 0.2% |
| Pharmacyclics Inc. | COM | 716933106 | $63.8K | 636,542 | 0.2% |
| Endocyte Inc. | COM | 29269A102 | $58.7K | 2,463,522 | 0.2% |
| Neurocrine Biosciences Inc.(NBIX) | COM | 64125C109 | $48.2K | 2,996,552 | 0.1% |
| ImmunoGen Inc.(IMGNEUR) | COM | 45253H101 | $47.3K | 3,165,816 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $33.8K | 488,188 | 0.1% |
| Theravance Inc. | COM | 88338T104 | $27.5K | 888,244 | 0.1% |
| Tesaro Inc. | COM | 881569107 | $17.8K | 604,582 | 0.1% |
| Infinity Pharmaceuticals Inc.(INFIQ) | COM | 45665G303 | $15.5K | 1,300,737 | 0.0% |
| Puma Biotechnology Inc.(PBYI) | COM | 74587V107 | $12.3K | 117,991 | 0.0% |
| Idenix Pharmaceuticals Inc. | COM | 45166R204 | $7.5K | 1,250,000 | 0.0% |
| Achillion Pharmaceuticals Inc.(ACHNEUR) | COM | 00448Q201 | $5.9K | 1,779,340 | 0.0% |
| Ariad Pharmaceuticals Inc. | COM | 04033A100 | $1.4K | 171,517 | 0.0% |
| Cubist Pharmaceuticals Inc. | RIGHT 99/99/9999 | 229678123 | $570 | 876,273 | 0.0% |